Disclosures for "Hemolysis, Elevated Liver Enzymes, and Low Platelets Syndrome Is Associated with Increased Risk of Ischemic Stroke in the Postpartum Period: Investigating Hypertensive Disorders of Pregnancy Subtypes Using the Nationwide Readmissions Database"
-
Dr. Moehl has nothing to disclose.
-
Alen Delic has nothing to disclose.
-
Dr. De Havenon has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novo Nordisk. Dr. De Havenon has or had stock in Certus.Dr. De Havenon has or had stock in TitinKM. The institution of Dr. De Havenon has received research support from NIH/NINDS. Dr. De Havenon has received publishing royalties from a publication relating to health care.